Insomnia Global Clinical Trials Review, H2, 2014

Date: July 14, 2014
Pages: 110
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: I9ABF9C1EAAEN
Leaflet:

Download PDF Leaflet

Insomnia Global Clinical Trials Review, H2, 2014

SUMMARY

GlobalData's clinical trial report, “Insomnia Global Clinical Trials Review, H2, 2014' provides data on the Insomnia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Insomnia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Insomnia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
REASONS TO BUY
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Insomnia
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Insomnia to Central Nervous System Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Insomnia to Central Nervous System Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Insomnia
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Insomnia Therapeutics Clinical Trials
Prominent Drugs
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Takeda Pharmaceutical Company Limited
Clinical Trial Overview of Takeda Pharmaceutical Company Limited
Merck & Co., Inc.
Clinical Trial Overview of Merck & Co., Inc.
Dainippon Sumitomo Pharma Co., Ltd.
Clinical Trial Overview of Dainippon Sumitomo Pharma Co., Ltd.
Sanofi
Clinical Trial Overview of Sanofi
Neurocrine Biosciences, Inc.
Clinical Trial Overview of Neurocrine Biosciences, Inc.
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Neurim Pharmaceuticals Ltd
Clinical Trial Overview of Neurim Pharmaceuticals Ltd
Eisai Co., Ltd.
Clinical Trial Overview of Eisai Co., Ltd.
Actelion Ltd
Clinical Trial Overview of Actelion Ltd
Clinical Trial Overview of Top Institutes / Government
University of Rochester
Clinical Trial Overview of University of Rochester
Duke University
Clinical Trial Overview of Duke University
U.S. Department of Veterans Affairs
Clinical Trial Overview of U.S. Department of Veterans Affairs
Karolinska Institute
Clinical Trial Overview of Karolinska Institute
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Brigham and Women's Hospital
Clinical Trial Overview of Brigham and Women's Hospital
Stanford University
Clinical Trial Overview of Stanford University
The University of Hong Kong
Clinical Trial Overview of The University of Hong Kong
Massachusetts General Hospital
Clinical Trial Overview of Massachusetts General Hospital
National Institute of Mental Health
Clinical Trial Overview of National Institute of Mental Health
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Insomnia Therapeutics, Global, Clinical Trials by Region, 2014*
Insomnia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
Insomnia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
Insomnia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
Insomnia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
Insomnia Therapeutics Clinical Trials, North America, Top Countries, 2014*
Insomnia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
Insomnia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
Proportion of Insomnia to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
Insomnia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
Insomnia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
Proportion of Insomnia to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
Insomnia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
Insomnia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
Insomnia Therapeutics, Global, Clinical Trials by Phase, 2014*
Insomnia Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
Insomnia Therapeutics, Global, Clinical Trials by Trial Status, 2014*
Insomnia Therapeutics Clinical Trials, Global, by End Point Status, 2014*
Insomnia Therapeutics, Global, Suspended Clinical Trials, 2014*
Insomnia Therapeutics, Global, Withdrawn Clinical Trials, 2014*
Insomnia Therapeutics, Global, Terminated Clinical Trials, 2014*
Insomnia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Insomnia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
Insomnia Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
Insomnia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
Insomnia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dainippon Sumitomo Pharma Co., Ltd., 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurocrine Biosciences, Inc., 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurim Pharmaceuticals Ltd, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rochester, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institute, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
Insomnia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014*

LIST OF FIGURES

Insomnia Therapeutics, Global, Clinical Trials by Region (%), 2014
Insomnia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Insomnia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Insomnia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Insomnia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Insomnia Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Insomnia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014
Insomnia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Insomnia to Central Nervous System Clinical Trials, G7 Countries (%), 2014
Insomnia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Insomnia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Insomnia to Central Nervous System Clinical Trials, E7 Countries (%), 2014
Insomnia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Insomnia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Insomnia Therapeutics, Global, Clinical Trials by Phase (%), 2014
Insomnia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Insomnia Therapeutics, Global, Clinical Trials by Trial Status, 2014
Insomnia Therapeutics Clinical Trials, Global, by End Point Status, 2014
Insomnia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Insomnia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Insomnia Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Insomnia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Insomnia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Insomnia Global Clinical Trials Review, H1, 2016 US$ 2,500.00 Jun, 2016 · 363 pages
Dysphagia Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Mar, 2016 · 60 pages
Hyperalgesia Global Clinical Trials Review, H1, 2016 US$ 2,125.00 Mar, 2016 · 94 pages

Ask Your Question

Insomnia Global Clinical Trials Review, H2, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: